Abstract
We read with great interest the recent publication of Unosson et al. investigating the association between the abdominal aortic aneurysm (AAA) growth rate, chemokine profile, and metformin prescription.1 Although AAA is most often associated with atherosclerotic cardiovascular risk factors, it is paradoxically negatively associated with diabetes mellitus and several studies have suggested that antidiabetic drugs, such as metformin, may contribute to protect against AAA development.2–6 In a cohort of 526 undergoing surveillance for small AAA, Unosson et al.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
